申请人:AstraZeneca AB
                            
                            
                                公开号:US20040186090A1
                            
                            
                                公开(公告)日:2004-09-23
                            
                            There is provided compounds of formula I
1
wherein R
1
, R
x
, Y, R
y
, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
                            提供了I1式化合物,其中R1、Rx、Y、Ry、n和B的含义如描述中所示,可用作竞争性蛋白酶抑制剂,例如凝血酶,特别是在需要抑制凝血酶的情况下(例如血栓形成)或作为抗凝剂的治疗。